Grace Therapeutics, Inc. (GRCE) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.71M | -2.22M | -3.15M | -1.8M | -2.95M | -4.12M | -4.24M | -3.6M | -2.09M | -1.89M | -2.11M | -6.24M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 42.23% | 46.09% | 25.58% | 49.92% | -41.48% | -117.49% | -100.62% | 42.37% | 37.22% | 49.17% | 38.56% | -15% |
| Net Income | -1.18M | -2.31M | -938K | -3.36M | 636K | -4.16M | -3.43M | -2.62M | -3.17M | -2.39M | -3.27M | -4.02M |
| Depreciation & Amortization | 2K | 3K | 0 | 2K | 2K | 2K | 2K | 1K | 1K | 1K | 2K | 7K |
| Stock-Based Compensation | -24K | 314K | 0 | 302K | 130K | 160K | 202K | 238K | 229K | 326K | 280K | 78K |
| Deferred Taxes | -1.7M | 0 | 0 | 0 | -1.02M | -605K | -852K | -724K | -889K | -208K | -446K | -289K |
| Other Non-Cash Items | 189.71K | -131.57K | -1.23M | 487K | -2.64M | 1.18M | -361K | -1.4M | 1.03M | -126K | 1.79M | 13K |
| Working Capital Changes | 1M | -88.78K | -983.5K | 770K | -66K | -695K | 202K | 901K | 704K | 506K | -464K | -2.03M |
| Change in Receivables | 1.48K | -1.27K | 250 | 106K | 175K | 114K | -19K | 326K | 237K | -122K | 0 | -35K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 15K | 0 | -15K | 6.55M | -6.55M | 110K | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -22K | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 110.07K | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 15K | 0 | 0 | 1K | 0 | -73 | 0 |
| Cash from Financing | -769 | 4.04M | -769 | -327K | 14.03M | 0 | 0 | 0 | 0 | 0 | 7.36M | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 51.88K | 5.51M | -769 | 0 | 15M | 0 | 0 | 0 | 0 | 0 | 7.34M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -52.65K | -1.47M | 0 | -327K | -967K | 0 | 0 | 0 | 0 | 0 | 21K | 0 |
| Net Change in Cash | -1.7M | 1.81M | -3.14M | -2.13M | 11.08M | -4.1M | -4.24M | -3.61M | 4.46M | -8.45M | 5.36M | -6.24M |
| Free Cash Flow | -1.71M | -2.22M | -3.15M | -1.8M | -2.95M | -4.12M | -4.24M | -3.6M | -2.11M | -1.89M | -2.11M | -6.24M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 42.23% | 46.09% | 25.58% | 49.92% | -40% | -117.49% | -100.62% | 42.37% | 36.71% | 49.17% | 38.59% | -14.85% |
| FCF per Share | -0.10 | -0.13 | -0.20 | -0.11 | -0.21 | -0.36 | -0.37 | -0.33 | -0.21 | -0.16 | -0.28 | -0.84 |
| FCF Conversion (FCF/Net Income) | 1.45x | 0.70x | 2.41x | 0.54x | -3.26x | 0.69x | 1.24x | 1.00x | 0.49x | 0.60x | 0.48x | 1.17x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |